Physician profile
Collene Greco
NPI 1154422624
$918.83
in general payments reported to CMS, 2019-2025
13 companies · $159 in 2025
The $159 reported for 2025 was less than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $75.50 · 2022: $125 · 2023: $299 · 2024: $261 · 2025: $159.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $719.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $718.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $165.23 | 2023-2025 | Dupixent |
| Abbvie INC. | $124.59 | 2022 | |
| Glaxosmithkline, LLC. | $123.82 | 2024 | Arexvy |
| Abbott Laboratories | $115.75 | 2023 | Thoratec Heartmate 3 Lvas Implant Kit |
| Leo Pharma INC. | $104.28 | 2021-2023 | Adbry |
| Janssen Biotech, INC. | $80.08 | 2023-2025 | Tremfya |
| Sun Pharmaceutical Industries INC. | $56.34 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $51.81 | 2024 | Farxiga, Airsupra, Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $22.75 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $22.70 | 2025 | |
| Phadia US INC. | $18.46 | 2024 | Immunocap |
| Hikma Pharmaceuticals USA | $18.06 | 2024 | Ryaltris |
| Merck Sharp & Dohme LLC | $14.96 | 2025 | Capvaxive |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Collene Greco listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.